Skip to main content
. 2015 Nov 21;21(43):12274–12282. doi: 10.3748/wjg.v21.i43.12274

Table 2.

Aberrant microRNA expression in human colonic tissue in Crohn’s disease

Status Tissue type Control Aberrant microRNA expression Ref.
Active CD Sigmoid, n = 5 Healthy Decreased: miR-19b and 629 Wu et al[26], 2010
Increased: miR-23b, 106a and 191
Terminal ileum, n = 6 Healthy Increased: miR-16, 21, 223, and 594 Wu et al[26], 2010
Colon, nonspecific, n = 16 Healthy Increased: miR-9, 21, 22, 26a, 29b, 29c, 30b, 31, 34c-5p, 106a, 126, 126*, 127-3p, 130a, 133b, 146a, 146b-5p, 150, 155, 181c, 196a, 324-3p and 375 Fasseu et al[19], 2010
Colon, nonspecific, n = 8 Healthy Decreased: miR-7 Nguyen et al[27], 2010
Colon, nonspecific, n = 120 Healthy Increased: miR-196 Brest et al[28], 2011
Active and inactive CD Colon, nonspecific, n = 15 Healthy Increased: miR-31 and 141 Huang et al[29], 2015
Colon, distalmost, n = 9 Healthy Decreased: miR-194b, 216b, 548e and 559 Increased: miR-31, 146a, 206 and 663 Lin et al[23], 2014
Inactive CD Colon, nonspecific, n = 8 Healthy Increased: miR-9*, 21, 22, 26a, 29b, 29c, 30a*, 30b, 30c, 31, 34c-5p, 106a, 126*, 127-3p, 133b, 146a, 146b-5p, 150, 155, 196a, 223 and 324-3p Fasseu et al[19], 2010
Active CD Colon, left or sigmoid, n = 9 Inactive CD Decreased: miR-18a*, 140-3p, 629* and let-7b Increased: miR-328, 422a and 885-5p Iborra et al[25], 2013

CD: Crohn’s disease; UC: Ulcerative colitis.